We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Cancer seen in the lungs of a human torso
Industry Insight

Addressing One of the Most Common Dilemmas Faced by Oncologists

Technology Networks spoke to Dr. Ofer Sharon, CEO of OncoHost, to learn about the challenges in non-small cell lung cancer treatment and how proteomics-based analysis could enable personalized cancer treatments.
Small molecule closeup
Industry Insight

Confident Metabolite Identification for Meaningful Results in Multiomics Analyses

In this interview, Technology Networks spoke to Heiko Neuweger, director of Bioinformatics Life Science Mass Spectrometry Software R&D at Bruker, to learn about the importance of target compound annotation and identification, the advantages of integrating collision cross section (CCS) information into workflows and the benefits of CCS-Predict Pro.
The D100 digital dispense by HP.
Industry Insight

Accelerating Single-Cell Research with Powerful Dispensing

Join us for an interview with HP's Christie Dudenhoefer, manager of Life Science Solutions, and Dr. Ryan Kelly, professor in the Department of Chemistry at Brigham Young University, to learn how HP's D100 single-cell dispenser is being utilized.
Two people in lab coats looking at an ACT label on a piece of analytical chemistry equipment.
Industry Insight

What Does Sustainability Accreditation Really Mean for Scientific Companies?

With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.
Scientists in a lab working at analytical machines while others analyse data at computers in the background.
Industry Insight

A New-Generation HPLC System Has Users at Its Heart

HPLC system manufacturers have been striving to improve usability, accessibility and help users improve their experimental outcomes. And what better way to do that than to involve the users themselves in that development process.
Illustration of DNA double helices with a flame pattern in the background.
Industry Insight

Gene Expression Analysis in Cancer Research

We spoke with Bio-Rad’s Justin Barker to discover some of the challenges associated with gene expression analysis in oncology and learn about technology developments in this field.
Photograph of the Agilent Measurement Suite at Imperial College London taken through the window.
Industry Insight

Flagship Facility Supports Advanced Analytical Science

We spoke to Prof. Oscar Ces, head of the Department of Chemistry at Imperial College London (ICL), to find out about the evolution of ICL’s White City Campus, the Agilent Measurement Suite and what it means for scientists across the board.
Protein structure.
Industry Insight

Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research

Cutting-edge mass spectrometry proteomics technologies are accelerating the discovery and validation of novel targets in cancer, opening up new avenues for next-generation cancer therapeutics.
Cancer patient with a line in her arm talking to a medic with a stethoscope around her neck.
Industry Insight

Next-Generation Proteomics Solutions Set To Accelerate Targeted Therapies

Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.
A picture depicting proteins within a cell.
Industry Insight

Increasing Throughput While Protecting Proteome Coverage

At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.
Advertisement